Participant baseline characteristics.
liver stiffness
*Tropism testing from HIV proviral DNA sequencing was successful for 39/53 (74%)cART combination antiretroviral therapy, CAP controlled attenuation parameter, INSTI integrase strand transfer inhibitor, LS liver stiffness, MVC maraviroc, NNRTI Non-nucleoside reverse transcriptase inhibitor, OBT optimised background therapy, PI protease inhibitor, TAF tenofovir alafenamide